3-iodobenzylguanidine has been researched along with Thyroid Neoplasms in 119 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 41 (34.45) | 18.7374 |
1990's | 35 (29.41) | 18.2507 |
2000's | 24 (20.17) | 29.6817 |
2010's | 15 (12.61) | 24.3611 |
2020's | 4 (3.36) | 2.80 |
Authors | Studies |
---|---|
Flux, G; Gape, P; Gear, J; Leek, F; Taprogge, J | 1 |
Andrási, M; Barna, S; Berta, E; Bhattoa, HP; Bodor, M; Erdei, A; Gazdag, A; Győry, F; Hircsu, I; Kanyári, Z; Nagy, B; Nagy, VE | 1 |
Jimenez, C; Núñez, R; Wendt, R | 1 |
Clement, SC; Klein Hesselink, MS; Lebbink, CA; Links, TP; Ronckers, CM; Teepen, JC; van Santen, HM | 1 |
Breza, J | 1 |
Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
Bombardieri, E; Chiti, A; Lorenzoni, A; Pepe, G | 1 |
Caron, HN; Clement, SC; Tytgat, GA; van Eck-Smit, BL; van Rijn, RR; van Santen, HM; van Trotsenburg, AS | 1 |
Besenyi, Z; Pávics, L | 1 |
Arnous, MM; Lan, X; Sun, X | 1 |
Angeletti, G; Avenia, N; Caracò, C; Chiofalo, MG; Colao, A; Faggiano, A; Ferolla, P; Grimaldi, F; Lombardi, G; Mozzillo, N; Pezzullo, L; Santeusanio, F | 1 |
Aliberti, G; Bombardieri, E; Castellani, MR; Chiesa, C; Maccauro, M; Orunesu, E; Seregni, E | 1 |
McEwan, AJ; Postema, EJ | 1 |
Bessa, B; Purisch, S; Rosário, PW; Salles, DS | 1 |
Baum, RP; Howman-Giles, R; Schmidt, M; Simon, T | 1 |
Bardiès, M; Buvat, I | 1 |
Divgi, C; Ilias, I; Pacak, K | 1 |
Bomanji, JB; Papathanasiou, ND | 1 |
Hopman, SM; Nieveen van Dijkum, EJ; Tytgat, GA; van de Wetering, MD; van der Steeg, AF; van Eck-Smit, BL; van Santen, HM; van Trotsenburg, AS | 2 |
Bennet, A; Caron, P; Grunenwald, S; Maiza, JC; Otal, P; Vezzosi, D | 1 |
Teszler, CB | 1 |
Drozd, T; Green, P; Hamdan, A; Hirsch, D; Molad, Y; Neumann, A | 1 |
An, R; Biersack, HJ; Ezziddin, S; Gao, Z; Logvinski, T | 1 |
Davis, DB; Kaplan, EL; Kim, J; Refetoff, S; Reutrakul, S | 1 |
McEwan, AJ; Pasieka, JL; Rorstad, O | 1 |
Aoi, S; Fumino, S; Iwai, N; Shimotake, T; Tsuda, T | 1 |
Baum, RP; Calcagni, ML; Rufini, V | 1 |
Ben Abdallah, N; Cheikhrouhou, H; Chérif, L; Hadj Ali, I; Héni, M; Khiari, K; Rajhi, H | 1 |
An, R; Biersack, HJ; Gao, ZR; Zhang, YX | 1 |
Bae, SJ; Chung, JH; Jung, HS; Kim, KW; Lee, MK; Lee, MS; Min, YK; Park, HK; Park, S; Yang, JH | 1 |
Bodei, L; Brans, B; Giammarile, F; Linden, O; Luster, M; Oyen, WJG; Tennvall, J | 1 |
Bodei, L; Brans, B; Giammarile, F; Luster, M; Maecke, HR; Oyen, WJ; Tennvall, J | 1 |
Bardies, M; Chiesa, C; Flux, G; Lassmann, M; Monsieurs, M; Savolainen, S; Strand, SE | 1 |
Al-Nahhas, A; Castaldi, P; Gross, MD; Perotti, G; Rubello, D; Rufini, V; Treglia, G | 1 |
Arumugam, P; Augustine, T; Malik, RA; Newton, TD | 1 |
Konishi, J; Makimoto, K; Miyauchi, A; Tada, J; Torizuka, K | 1 |
Endo, K; Kasagi, K; Konishi, J; Nakao, K; Shiomi, K; Tanimura, H; Torizuka, K | 1 |
Connell, JM; Elliott, A; Hilditch, TE; Semple, PF | 1 |
Beierwaltes, WH; Freitas, JE; Gross, MD; Shapiro, B; Thrall, JH | 1 |
Beierwaltes, WH; Frager, MS; Gross, MD; Mangner, TJ; Sisson, JC; Swanson, DP; Valk, TW; Wieland, DM | 1 |
Amano, M; Kitahara, T; Koizumi, M; Nomura, E; Okajima, Y; Okizuka, H; Sawano, S; Yamada, K; Yamada, Y; Yamashita, T | 1 |
Bito, S; Dan, Y; Hino, M; Ikekubo, K; Ito, H; Masui, Y; Ohta, K; Ootsuka, H; Saiki, Y; Yamaguchi, H | 1 |
Albertson, DA; Cooper, MR; Cowan, RJ; Thomas, CC | 1 |
D'Ajello, M; Marzano, LA; Porcelli, A; Zarrilli, L; Zarrilli, S | 1 |
Advani, SH; Kurkure, PA; Murugesan, S; Noronha, OP; Samuel, AM; Sonawane, GA | 1 |
Donfrancesco, F; Mastrangelo, R; Riccardi, R; Rufini, V; Troncone, L; Turba, R | 1 |
Endo, K; Hirano, T; Inoue, T; Ishida, T; Tomiyoshi, K; Zhang, YJ | 1 |
Coutris, G; Mensch, B; Montravers, F; Sarda, L; Talbot, JN | 1 |
Clarke, SE | 3 |
Liewendahl, K; Taavitsainen, M; Välimäki, M | 1 |
Bajetta, E; Buzzoni, R; Castellani, R; Celio, L; de Braud, F; Di Bartolomeo, M; Lorusso, V; Maffioli, L; Villa, E; Zilembo, N | 1 |
Einert, A; Laubenberger, JJ; Moser, E; Nitzsche, EU; Simon, GH | 1 |
Lin, WY; Shen, YY; Wang, SJ | 1 |
Gaze, MN | 1 |
Bolster, AA; Hilditch, TE | 1 |
Bertocchi, C; Mazzoni, A; Medolago, G; Moschini, L; Torre, L; Virotta, G; Zappone, C | 1 |
Gross, MD; Shapiro, B; Shulkin, BL; Sisson, JC; Zempel, S | 1 |
Han, R; Mitrovic, S; Zagar, I | 1 |
Casolo, A; Corsello, SM; Martino, G; Maussier, ML; Pantusa, M; Rufini, V; Saletnich, I; Salvatori, M; Troncone, L; Valenza, V | 1 |
Acampa, W; Bernardy, JD; Klain, M; Lastoria, S; Maurea, S; Muto, P; Salvatore, M; Varrella, P; Vergara, E | 1 |
Delisle, MJ; Liehn, JC; Pérault, C; Schvartz, C; Wampach, H | 1 |
Isobe, Y; Kihara, M; Kobayashi, S; Matsusaka, K; Miyauchi, A; Nishiyama, Y; Ohkawa, M; Takashima, H; Tanabe, M; Yamamoto, Y | 1 |
Oyamada, H | 1 |
Kinuya, S; Tonami, N; Yokoyama, K | 1 |
Ferraironi, A; Festa, A; Maini, CL; Rea, S; Sciuto, R; Tofani, A | 1 |
Chisin, R; Glaser, B; Guttmann, H; Ish-Shalom, S; Krausz, Y; Rosler, A; Shibley, N | 1 |
Hara, Y; Hayashi, A; Horiike, S; Ishii, K; Kubo, A; Kusakabe, K; Masaki, H; Murata, H | 1 |
Chatal, JF; Kraeber-Bodéré, F; Le Bodic, MF; Resche, I; Rousseau, C | 1 |
Iwata, M; Kasagi, K; Konishi, J; Misaki, T; Sakahara, H | 1 |
Besser, GM; Britton, KE; Chew, SL; Foley, R; Grossman, AB; Heintz, E; Jenkins, PJ; Kaltsas, G; Korbonits, M; Monson, JP; Mukherjee, JJ; Reznek, R | 1 |
Besser, GM; Britton, KE; Chew, SL; Foley, R; Grossman, AB; Hikmat, J; Islam, N; Jenkins, PJ; Kaltsas, GA; Monson, JP; Mukherjee, JJ; Plowman, PN | 1 |
Bais, E; Boot, H; de Kraker, J; Hoefnagel, CA; Taal, B; Valdés Olmos, RA; Vote, PA | 1 |
Brans, B; Dierckx, RA; Kaufman, JM; Laureys, G; Monsieurs, M; Thierens, H | 1 |
Endo, K; Kaneko, M; Kubo, A; Kusakabe, K; Masaki, H; Nakajo, M; Sasaki, Y; Yamashita, M | 1 |
Skowsky, WR; Wilf, LH | 1 |
Adams, BK; Byrne, MJ; Fataar, A; Levitt, NS; Matley, PJ | 1 |
Munz, DL; Sandrock, D | 1 |
Biondi, B; Lastoria, S; Lombardi, G; Lupoli, G; Pacilio, G; Panza, N; Salvatore, M | 1 |
Shapiro, B; Shulkin, BL | 1 |
Ahuja, S; Ernst, H; Koppenhagen, K | 1 |
Danza, FM; Lasorella, A; Mastrangelo, R; Montemaggi, P; Rufini, V; Troncone, L | 1 |
Legnaioli, M; Maussier, ML; Montemaggi, P; Rufini, V; Troncone, L; Valenza, V | 1 |
Bestagno, M; Giubbini, R; Guerra, UP; Maira, G; Pagliaini, R; Pizzocaro, C; Terzi, A | 1 |
Blossey, HC; Munz, DL; Sandrock, D; Steinroeder, M | 1 |
De Rosa, G; Rufini, V; Testa, A; Troncone, L | 1 |
Banfi, F; Di Sacco, G; Libroia, A; Muratori, F; Verga, U | 1 |
Berna, L; Cabezas, RC; Carrio, I; Estorch, M; Garcia-Ameijeiras, A | 1 |
Fawcett, HD; James, E; Lieg, JL; Nusynowitz, ML; Poston, GJ; Thompson, JC; Townsend, CM | 1 |
Clarke, SE; Lazarus, CR; Maisey, MN | 1 |
Clarke, SE; Lazarus, CR; Maisey, MN; Sampson, C; Wraight, P | 1 |
Delprat, CC; Hoefnagel, CA; van der Schoot, JB; Zanin, D | 1 |
Chamouard, P; Constantinesco, A; Jouin, H; Varra, A; Weill, JP | 1 |
Lavender, JP; Lynn, JA; MacDonald, DW; Poston, GJ; Thomas, AM | 1 |
Hirayu, H; Izumi, M; Kakezono, F; Kiriyama, T; Kubo, I; Morita, S; Nagayama, Y; Ohtakara, S; Yamashita, S; Yokoyama, N | 1 |
George, P; Henderson, BL; Karvounaris, D; Lavender, JP; Lynn, JA; Macdonald, DW; Poston, GJ; Thomas, AM | 1 |
Endo, K; Hazama, F; Imura, H; Itoh, H; Kawase, M; Mukaino, S; Nakao, K; Sugie, K; Torizuka, K; Toyooka, S | 1 |
Hirota, Y; Oishi, S; Sasaki, M; Sato, T; Takahashi, M | 1 |
Ansari, AN; DeQuattro, V; Gazarian, LH; Siegel, ME | 1 |
Baulieu, F; Baulieu, JL; Coutris, G; Delépine, N; Delisle, MJ; Dupont, JL; Gardet, P; Guilloteau, D; Perdrisot, R; Talbot, JN | 1 |
Basso, LV; Keeling, CA | 1 |
Endo, K; Fujita, T; Inoue, G; Koizumi, M; Konishi, J; Maki, A; Mori, K; Nakano, Y; Ohta, H; Ozawa, K | 1 |
Bigorgne, JC; Jallet, P; Lejeune, JJ; Perdrisot, R; Rohmer, V | 1 |
Duranceau, A; Laflamme, L; Schürch, W; Taillefer, R; Verdy, M | 1 |
Charbonnel, B; Chatal, JF; Krempf, M | 1 |
Connell, JM; Elliot, AT; Hilditch, TE; Murray, T; Reed, NS | 1 |
Beals, E; Beierwaltes, WH; Gross, MD; Lloyd, R; McEwan, AJ; Shapiro, B; Sisson, JC; Thompson, NW; Von Moll, L | 1 |
Bigorgne, JC; Getin, F; Jallet, P; Rohmer, V; Saint Andre, JP | 1 |
Fukunaga, M; Harada, T; Morita, R; Muranaka, A; Nakayama, H; Otsuka, N; Sone, T; Tomomitsu, T; Yanagimoto, S | 1 |
Hisada, K; Michigishi, T; Tonami, N; Yokoyama, K | 1 |
de la Calle, H; de Pablos, PL; Estopiñán, V; Hurtado, A | 1 |
de Kraker, J; Evans, AE; Green, A; Hayes, A; Hoefnagel, CA; Voûte, PA | 1 |
Clarke, DG; Clarke, SE; Edwards, S; Fogelman, I; Lazarus, CR; Maisey, MN; Murby, B; Roden, TM | 1 |
Calmettes, C; Coutris, G; Kabla, G; Milhaud, G; Talbot, JN | 1 |
Danza, FM; Lasorella, A; Maini, CL; Rufini, V; Troncone, L; Valenza, V | 1 |
Mahler, C; Mertens, J; Roland, J; Sand, A; Vandevivere, J; Vanryckeghem, W | 1 |
Baulieu, JL; Besnard, JC; Guilloteau, D | 1 |
28 review(s) available for 3-iodobenzylguanidine and Thyroid Neoplasms
Article | Year |
---|---|
Iodine-131 and Iodine-131-Meta-iodobenzylguanidine Dosimetry in Cancer Therapy.
Topics: 3-Iodobenzylguanidine; Adult; Child; Humans; Iodine Radioisotopes; Multicenter Studies as Topic; Neuroendocrine Tumors; Radiometry; Radiotherapy Dosage; Thyroid Neoplasms | 2022 |
High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Humans; Intestinal Neoplasms; Iodine Radioisotopes; Neoplasm Metastasis; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Rare Diseases; Stomach Neoplasms; Therapies, Investigational; Thyroid Neoplasms | 2020 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Contraindications; Humans; Intestinal Neoplasms; Lung Neoplasms; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Pituitary Neoplasms; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Stomach Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2014 |
[Nuclear medicine in oncotherapy].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Neoplasms; Humans; Interdisciplinary Communication; Iodine Radioisotopes; Liver Neoplasms; Medical Oncology; Neuroendocrine Tumors; Nuclear Medicine; Prevalence; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radium; Receptors, Somatostatin; Thyroid Neoplasms | 2015 |
MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
Topics: 3-Iodobenzylguanidine; Carcinoma, Medullary; Humans; Neoplasm Metastasis; Neoplasm, Residual; Proto-Oncogene Mas; Recurrence; Thyroid Neoplasms | 2008 |
Radioiodinated metaiodobenzylguanidine treatment of neuroendocrine tumors in adults.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Algorithms; Carcinoid Tumor; Carcinoma, Medullary; Drug Interactions; Humans; Iodine Radioisotopes; Male; Medical Oncology; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals; Thyroid Neoplasms | 2009 |
Therapeutic nuclear medicine in pediatric malignancy.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Child; Combined Modality Therapy; Humans; Iodine Radioisotopes; Neoplasms; Neuroblastoma; Neuroendocrine Tumors; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Receptors, Somatostatin; Thyroid Neoplasms | 2010 |
Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?
Topics: 3-Iodobenzylguanidine; Bone Marrow; Carcinoma, Hepatocellular; Humans; Iodine Radioisotopes; Liver Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Neuroendocrine Tumors; Nuclear Medicine; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Animals; Biological Transport; Carcinoma, Neuroendocrine; Humans; Pheochromocytoma; Thyroid Neoplasms | 2011 |
¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Carcinoma, Neuroendocrine; Humans; Iodine Radioisotopes; Neuroendocrine Tumors; Octreotide; Paraganglioma; Pentetic Acid; Pheochromocytoma; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms | 2012 |
Imaging of neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; ACTH Syndrome, Ectopic; Adrenal Gland Neoplasms; Adult; Carcinoma, Medullary; Catecholamines; Child; Gastrointestinal Neoplasms; Humans; Iodine Radioisotopes; Middle Aged; Neuroblastoma; Neuroendocrine Tumors; Octreotide; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin; Thyroid Neoplasms | 2006 |
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
Topics: 3-Iodobenzylguanidine; Animals; Clinical Trials as Topic; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Lymphoma; Maximum Tolerated Dose; Neuroendocrine Tumors; Peptides; Radioimmunotherapy; Radiometry; Radiotherapy; Thyroid Neoplasms | 2007 |
Targeted therapy in nuclear medicine--current status and future prospects.
Topics: 3-Iodobenzylguanidine; Female; Forecasting; Hematologic Neoplasms; Humans; Indium Radioisotopes; Male; Neoplasms; Neuroblastoma; Nuclear Medicine; Ovarian Neoplasms; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Survival Analysis; Thyroid Neoplasms; Treatment Outcome | 2007 |
Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Animals; Carcinoembryonic Antigen; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2008 |
The scintigraphic imaging of endocrine organs.
Topics: 3-Iodobenzylguanidine; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Glands; Cushing Syndrome; Endocrine Glands; Female; Humans; Hyperaldosteronism; Iodine Radioisotopes; Iodobenzenes; Male; Ovary; Pancreas; Parathyroid Glands; Pheochromocytoma; Pituitary Gland; Radionuclide Imaging; Technetium; Testis; Thyroid Gland; Thyroid Neoplasms | 1984 |
[Medullary carcinoma of the thyroid gland].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Child; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Iodine Radioisotopes; Iodobenzenes; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Parathyroid Hormone; Prognosis; Thyroid Neoplasms; Thyroidectomy | 1994 |
Nuclear medicine imaging in pediatric oncology.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Neoplasms; Child; Histiocytosis, Langerhans-Cell; Humans; Iodine Radioisotopes; Iodobenzenes; Leukemia; Lymphoma; Neoplasms; Neuroblastoma; Radionuclide Imaging; Thyroid Neoplasms | 1994 |
Radionuclide therapy in oncology.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Bone Neoplasms; Brachytherapy; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasms; Phosphorus Radioisotopes; Radioisotopes; Radiotherapy Dosage; Rhenium; Samarium; Strontium Radioisotopes; Thyroid Neoplasms | 1994 |
The current status of targeted radiotherapy in clinical practice.
Topics: 3-Iodobenzylguanidine; Adult; Bone Neoplasms; Child; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Leukemia; Lymphoma; Neoplasms; Neuroblastoma; Ovarian Neoplasms; Palliative Care; Polycythemia; Radioimmunotherapy; Radiotherapy; Thyroid Neoplasms | 1996 |
The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoid Tumor; Carcinoma, Medullary; Heart; Hormone Antagonists; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radiology, Interventional; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Sympathetic Nervous System; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
[Internal radiation therapy for malignant neoplasm].
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Humans; Iodine Radioisotopes; Neuroblastoma; Pain; Palliative Care; Strontium Radioisotopes; Thyroid Neoplasms; Thyroidectomy | 1999 |
Nuclear medicine applications for neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Female; Humans; Male; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Pheochromocytoma; Prognosis; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2000 |
[Recent progress in radionuclide therapy].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Graves Disease; Humans; Iodine Radioisotopes; Prognosis; Radiopharmaceuticals; Strontium Radioisotopes; Thyroid Neoplasms | 2000 |
[Therapeutic advances of nuclear medicine in oncology].
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma; Carcinoma, Medullary; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Humans; Hyperbaric Oxygenation; Iodine Radioisotopes; Liver Neoplasms; Lymphoma; Medical Oncology; Neoplasms; Neuroblastoma; Nuclear Medicine; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2001 |
Radionuclide therapy of the thyroid.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Iodobenzenes; Thyroid Diseases; Thyroid Neoplasms | 1991 |
Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
Topics: 3-Iodobenzylguanidine; Aged; Antineoplastic Agents; Carcinoma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Organotechnetium Compounds; Radionuclide Imaging; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Tomography, X-Ray Computed | 1991 |
Iodine-131 MIBG uptake in metastatic medullary carcinoma of the thyroid. A patient treated with somatostatin.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Carcinoma; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia; Octreotide; Radionuclide Imaging; Somatostatin; Spinal Neoplasms; Thyroid Neoplasms | 1988 |
6 trial(s) available for 3-iodobenzylguanidine and Thyroid Neoplasms
Article | Year |
---|---|
The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I/123I-MIBG as predictors for radionuclide therapy.
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Patient Selection; Pentetic Acid; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2004 |
[Targeted radionuclide therapy for patients with metastatic medullary thyroid carcinoma].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Carcinoma, Medullary; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Male; Middle Aged; Octreotide; Pentetic Acid; Positron-Emission Tomography; Remission Induction; Thyroid Gland; Thyroid Hormones; Thyroid Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2006 |
[Detection of neural crest tumors by 123I-MIBG scintigraphy].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1994 |
Salvage treatment after r-interferon alpha-2a in advanced neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adenoma, Islet Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Carcinoma, Merkel Cell; Drug Administration Schedule; Endocrine Gland Neoplasms; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neurosecretory Systems; Pancreatic Neoplasms; Recombinant Proteins; Salvage Therapy; Streptozocin; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 1993 |
[Evaluation of clinical utility of 123I-MIBG scintigraphy in localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2000 |
[The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1992 |
85 other study(ies) available for 3-iodobenzylguanidine and Thyroid Neoplasms
Article | Year |
---|---|
[Multiple endocrine neoplasia type 2A in a family].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Female; Goiter, Nodular; Humans; Metanephrine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Parathyroid Neoplasms; Pheochromocytoma; Ribosomal Proteins; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy | 2020 |
Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Age of Onset; Antineoplastic Agents; Biopsy; Cancer Survivors; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Self Report; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Ultrasonography; Young Adult | 2020 |
Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Carcinoma, Neuroendocrine; Child; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Mutation; Pedigree; Pheochromocytoma; Polymerase Chain Reaction; Positron Emission Tomography Computed Tomography; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2018 |
Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Hypothyroidism; Infant; Male; Neoplasms, Radiation-Induced; Neuroblastoma; Radiopharmaceuticals; Radiotherapy; Thyroid Neoplasms | 2015 |
Multiple Endocrine Neoplasia Type 2B Unmasked by 18 F-FDG PET/CT and 131 I-MIBG SPECT/CT.
Topics: 3-Iodobenzylguanidine; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multiple Endocrine Neoplasia Type 2b; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Thyroid Neoplasms | 2017 |
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Contribution of scintigraphy and ultrasonography to the prediction of malignancy in thyroid nodules with indeterminate cytology.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Papillary; Child; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule; Ultrasonography; Young Adult | 2010 |
Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Carcinoma; Carcinoma, Papillary; Child; Female; Humans; Iodine Radioisotopes; Male; Neuroblastoma; Thoracic Neoplasms; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Ultrasonography | 2012 |
Use of 131 I-MIBG therapy in MIBG-positive metastatic medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma, Neuroendocrine; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Differentiated thyroid carcinoma after iodine-131 metaiodobenzylguanidine treatment for neuroblastoma: assessment of causality.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Female; Humans; Male; Neuroblastoma; Thoracic Neoplasms; Thyroid Neoplasms; Ultrasonography | 2013 |
Response to teszler.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Female; Humans; Male; Neuroblastoma; Thoracic Neoplasms; Thyroid Neoplasms; Ultrasonography | 2013 |
Pheochromocytoma: unusual presentation of a rare disease.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Medullary; Diagnosis, Differential; Disease-Free Survival; Follow-Up Studies; Humans; Low Back Pain; Lumbar Vertebrae; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Osteolysis; Pelvis; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Spinal Neoplasms; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tomography, X-Ray Computed | 2002 |
Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Cardiomyopathies; Catecholamines; Female; Humans; Labor, Obstetric; Metanephrine; Multiple Endocrine Neoplasia Type 2a; Pedigree; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Proto-Oncogene Mas; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2004 |
The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cohort Studies; Female; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Palliative Care; Radiopharmaceuticals; Thyroid Neoplasms; Treatment Outcome | 2004 |
Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B.
Topics: 3-Iodobenzylguanidine; Adolescent; Carcinoma, Medullary; Child; Female; Follow-Up Studies; Humans; Multiple Endocrine Neoplasia Type 2b; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2005 |
[Malignant pheochromocytomas: about three cases].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carcinoma, Papillary; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2006 |
Bilateral pheochromocytoma associated with paraganglioma and papillary thyroid carcinoma: report of an unusual case.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Biopsy, Needle; Carcinoma, Papillary; Female; Humans; Lymph Node Excision; Multiple Endocrine Neoplasia; Paraganglioma; Pheochromocytoma; Proto-Oncogene Mas; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2007 |
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
Topics: 3-Iodobenzylguanidine; Animals; Clinical Trials as Topic; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Lymphoma; Maximum Tolerated Dose; Neuroendocrine Tumors; Peptides; Radioimmunotherapy; Radiometry; Radiotherapy; Thyroid Neoplasms | 2007 |
Detection of medullary thyroid cancer with MIBG imaging for pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Female; Humans; Incidental Findings; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
[Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals].
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Radionuclide Imaging; Succimer; Sulfhydryl Compounds; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms | 1984 |
Imaging of medullary thyroid cancer with 131I-MIBG.
Topics: 3-Iodobenzylguanidine; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Multiple Endocrine Neoplasia; Radionuclide Imaging; Thyroid Neoplasms | 1984 |
131I-MIBG and medullary carcinoma of the thyroid.
Topics: 3-Iodobenzylguanidine; Carcinoma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Radionuclide Imaging; Thyroid Neoplasms | 1984 |
Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Carcinoma; Catecholamines; Endocrine System Diseases; Female; Guanidines; Humans; Iodine Radioisotopes; Male; Neoplasms, Multiple Primary; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms; Tomography, X-Ray Computed | 1981 |
Scintigraphic detection of recurrence of medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Humans; Iodobenzenes; Male; Middle Aged; Radionuclide Imaging; Recurrence; Succimer; Thyroid Neoplasms | 1995 |
Detection of medullary carcinoma of the thyroid with I-131 MIBG.
Topics: 3-Iodobenzylguanidine; Adenocarcinoma, Follicular; Antineoplastic Agents; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sulfur Colloid; Thyroid Neoplasms | 1994 |
131I-MIBG scintigraphy in neural crest tumours.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma, Medullary; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neural Crest; Neuroblastoma; Radionuclide Imaging; Sensitivity and Specificity; Thyroid Neoplasms | 1994 |
Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Carcinoma, Medullary; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Organotechnetium Compounds; Radionuclide Imaging; Reagent Kits, Diagnostic; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thallium; Thallium Radioisotopes; Thyroid Neoplasms | 1994 |
Utility of thallium-201 and iodine-123 metaiodobenzylguanidine in the scintigraphic detection of neuroendocrine neoplasia.
Topics: 3-Iodobenzylguanidine; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Thallium Radioisotopes; Thyroid Neoplasms | 1993 |
Localization of hepatic metastases by radiolabelled anti-carcinoembryonic antigen antibody and meta-iodobenzylguanidine in a patient with medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Aged; Carcinoma; Contrast Media; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Radioimmunodetection; Thyroid Neoplasms | 1993 |
PET imaging of recurrent medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Carcinoma, Medullary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Recurrence; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 1996 |
Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.
Topics: 3-Iodobenzylguanidine; Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Nausea; Pain; Prospective Studies; Radionuclide Imaging; Radiotherapy, Adjuvant; Thyroid Neoplasms; Xerostomia | 1996 |
The radiation dose to the urinary bladder in radio-iodine therapy.
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Metabolic Clearance Rate; Models, Theoretical; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms; Urinary Bladder Neoplasms | 1996 |
Meta-[123I]iodobenzylguanidine single photon emission computed tomography in chemodectomas.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Angiography, Digital Subtraction; Carcinoma, Papillary; Diagnosis, Differential; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Paraganglioma, Extra-Adrenal; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1995 |
Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carcinoid Tumor; Carcinoma, Medullary; Child; False Negative Reactions; False Positive Reactions; Follow-Up Studies; Heart; Humans; Hyperaldosteronism; Injections, Intravenous; Insulinoma; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Myocardium; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Salivary Glands; Sensitivity and Specificity; Thyroid Neoplasms | 1995 |
Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents, Hormonal; Calcitonin; Carcinoid Tumor; Carcinoma, Medullary; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Octreotide; Organotechnetium Compounds; Radiopharmaceuticals; Somatostatin; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 1995 |
Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Carcinoid Tumor; Carcinoma, Medullary; Carcinoma, Merkel Cell; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organotechnetium Compounds; Pheochromocytoma; Pituitary Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Skin Neoplasms; Sugar Acids; Technetium Compounds; Thyroid Neoplasms | 1995 |
Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Carcinoid Tumor; Carcinoma, Medullary; Feasibility Studies; Humans; Image Processing, Computer-Assisted; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Octreotide; Pentetic Acid; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Technetium Tc 99m Medronate; Thoracic Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1997 |
Iodine-131 MIBG imaging in multiple endocrine neoplasia type 2B.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenalectomy; Carcinoma, Medullary; Humans; Hyperplasia; Iodine Radioisotopes; Lymphatic Metastasis; Male; Multiple Endocrine Neoplasia Type 2b; Neoplasm Staging; Pheochromocytoma; Precancerous Conditions; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 1998 |
[Present status of unsealed radioisotope therapy in Japan based on the nation-wide questionnaire].
Topics: 3-Iodobenzylguanidine; Humans; Hyperthyroidism; Iodine Radioisotopes; Japan; Surveys and Questionnaires; Thyroid Diseases; Thyroid Neoplasms | 1999 |
Myocardial 123I-MIBG kinetics in acutely hypothyroid patients with differentiated thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Heart; Humans; Hypothyroidism; Kinetics; Male; Middle Aged; Norepinephrine; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyroxine; Triiodothyronine | 1999 |
Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Bone Neoplasms; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multiple Endocrine Neoplasia Type 2b; Octreotide; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed; Trachea | 1999 |
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Carcinoid Tumor; Child; Female; Humans; Indium Radioisotopes; Insulinoma; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2001 |
Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoid Tumor; Carcinoma, Medullary; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Thyroid Neoplasms; Treatment Outcome | 2001 |
Thyroidal uptake and radiation dose after repetitive I-131-MIBG treatments: influence of potassium iodide for thyroid blocking.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Dose-Response Relationship, Radiation; Drug Administration Schedule; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Middle Aged; Neoplasms, Radiation-Induced; Neuroendocrine Tumors; Potassium Iodide; Premedication; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Thyrotropin | 2002 |
Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia; Organotechnetium Compounds; Pheochromocytoma; Radionuclide Imaging; Succimer; Sulfhydryl Compounds; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms | 1990 |
[The diagnosis of thyroid carcinoma].
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Carcinoma; Contrast Media; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Radionuclide Imaging; Technetium; Thallium Radioisotopes; Thyroid Neoplasms | 1991 |
(131I)meta-iodobenzylguanidine scintigraphy and selective venous catheterization after thyroidectomy for medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma; Catheterization, Central Venous; Catheterization, Peripheral; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Radionuclide Imaging; Thyroid Neoplasms; Thyroidectomy | 1991 |
The role of imaging tests in the diagnosis of thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Citrates; Citric Acid; Contrast Media; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Radionuclide Angiography; Sodium Pertechnetate Tc 99m; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thallium Radioisotopes; Thyroid Neoplasms; Tomography; Ultrasonography | 1990 |
[The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)].
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma; Contrast Media; Drug Evaluation; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radionuclide Imaging; Thyroid Neoplasms; Time Factors | 1990 |
The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1990 |
The possible use of radioiodinated metaiodobenzylguanidine (MIBG) in medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Carcinoma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Radionuclide Imaging; Thyroid Neoplasms | 1988 |
New tracers for the imaging of the medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Calcitonin; Carcinoma; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Organometallic Compounds; Succimer; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Tomography, Emission-Computed | 1989 |
Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Antibodies, Monoclonal; Carcinoembryonic Antigen; Carcinoma; Female; Follow-Up Studies; Humans; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia; Pheochromocytoma; Radionuclide Imaging; Recurrence; Technetium; Thyroid Neoplasms; Tosyl Compounds | 1989 |
Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Carcinoembryonic Antigen; Carcinoma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia; Organotechnetium Compounds; Pheochromocytoma; Prognosis; Recurrence; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Tomography, Emission-Computed | 1989 |
The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Calcitonin; Carcinoma; Child; Female; Humans; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia; Organotechnetium Compounds; Radionuclide Imaging; Recurrence; Succimer; Sulfhydryl Compounds; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Thyroidectomy | 1989 |
Localization of metastases from medullary thyroid carcinoma using different methods.
Topics: 3-Iodobenzylguanidine; Adult; Antibodies, Monoclonal; Calcitonin; Carcinoembryonic Antigen; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neoplasm Metastasis; Recurrence; Thyroid Neoplasms; Tomography, Emission-Computed | 1989 |
Uptake of 131I-metaiodobenzylguanidine by 6-23 rat medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Animals; Calcitonin Gene-Related Peptide; Carcinoma; Colonic Neoplasms; Enterochromaffin Cells; Ileum; Iodine Radioisotopes; Iodobenzenes; Mice; Neoplasm Transplantation; Neuropeptides; Pheochromocytoma; Rats; Thyroid Neoplasms; Tissue Distribution; Tumor Cells, Cultured | 1989 |
Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Evaluation Studies as Topic; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organometallic Compounds; Radionuclide Imaging; Soft Tissue Neoplasms; Succimer; Sulfhydryl Compounds; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms | 1987 |
Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Carcinoma; Humans; Iodine Radioisotopes; Iodobenzenes; Organometallic Compounds; Radionuclide Imaging; Succimer; Sulfhydryl Compounds; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Medronate; Thyroid Neoplasms | 1988 |
New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Carcinoma; Humans; Iodine Radioisotopes; Iodobenzenes; Organometallic Compounds; Radioactive Tracers; Radioisotopes; Radionuclide Imaging; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thallium Radioisotopes; Thyroid Neoplasms | 1988 |
Radionuclide imaging in thyroid cancer.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Iodobenzenes; Organometallic Compounds; Radionuclide Imaging; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms | 1988 |
[Medullary cancer of the thyroid in type IIB multiple endocrine neoplasia. Uptake of meta-iodo-benzylguanidine labeled with iodine 131].
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Multiple Endocrine Neoplasia; Radionuclide Imaging; Thyroid Neoplasms | 1985 |
131I-MIBG uptake by medullary carcinoma of thyroid.
Topics: 3-Iodobenzylguanidine; Carcinoma; Humans; Iodobenzenes; Thyroid Neoplasms | 1985 |
[Clinical applications of 131I-meta iodobenzylguanidine (131I-MIBG) scintigraphy in Japan].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma; Humans; Iodobenzenes; Japan; Multiple Endocrine Neoplasia; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1986 |
Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.
Topics: 3-Iodobenzylguanidine; Adult; Calcitonin; Carcinoma; Epinephrine; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia; Neoplasm Metastasis; Norepinephrine; Radionuclide Imaging; Thyroid Neoplasms; Thyroidectomy; Thyroxine | 1986 |
Detection of metastatic medullary thyroid cancer with 131I-MIBG scans in Sipple's syndrome.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma; Female; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Mediastinal Neoplasms; Middle Aged; Multiple Endocrine Neoplasia; Pheochromocytoma; Radionuclide Imaging; Skull Neoplasms; Thyroid Neoplasms | 1986 |
Imaging and uptake mechanism of 131I-meta-iodobenzylguanidine in medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Carcinoma; Epinephrine; Female; Humans; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia; Norepinephrine; Radionuclide Imaging; Thyroid Neoplasms | 1986 |
Imaging of medullary thyroid carcinoma and hyperfunctioning adrenal medulla using iodine-131 metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Hyperfunction; Adult; Carcinoma; Female; Humans; Hyperplasia; Iodobenzenes; Multiple Endocrine Neoplasia; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1986 |
Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Calcitonin; Carcinoma; Child; Evaluation Studies as Topic; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1987 |
Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Carcinoma; Carcinoma, Hepatocellular; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Multiple Endocrine Neoplasia; Neoplasms, Multiple Primary; Organometallic Compounds; Pheochromocytoma; Radionuclide Imaging; Succimer; Sulfhydryl Compounds; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms | 1988 |
Thyroid uptake of MIBG in Sipple's syndrome.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Carcinoma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia; Radionuclide Imaging; Thyroid Neoplasms | 1988 |
Medullary thyroid carcinoma: localization of a mediastinal metastasis with I-131 MIBG.
Topics: 3-Iodobenzylguanidine; Adult; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Mediastinal Neoplasms; Multiple Endocrine Neoplasia; Radionuclide Imaging; Thyroid Neoplasms | 1988 |
[Medullary thyroid cancer may take up meta-iodobenzylguanidine].
Topics: 3-Iodobenzylguanidine; Aged; Carcinoma; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Radionuclide Imaging; Thyroid Neoplasms | 1985 |
Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Carcinoma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Radionuclide Imaging; Succimer; Sulfhydryl Compounds; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms | 1986 |
Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
Topics: 3-Iodobenzylguanidine; Aged; Apudoma; Carcinoid Tumor; Carcinoma; Carotid Body Tumor; Choriocarcinoma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neurilemmoma; Paraganglioma; Paraganglioma, Extra-Adrenal; Pregnancy; Radionuclide Imaging; Thyroid Neoplasms | 1987 |
[Localization of medullary cancer of the thyroid gland by scintigraphy using meta-iodo-benzylguanidine].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Carcinoma; Female; Humans; Iodobenzenes; Radionuclide Imaging; Thyroid Neoplasms | 1985 |
Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Diphosphonates; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Middle Aged; Radionuclide Imaging; Spinal Neoplasms; Technetium; Technetium Tc 99m Medronate; Thyroid Neoplasms | 1985 |
[Image diagnosis: nuclear medicine].
Topics: 3-Iodobenzylguanidine; Citrates; Citric Acid; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Neoplasms; Radionuclide Imaging; Skin Neoplasms; Thyroid Neoplasms | 1988 |
[131-I-MIBG and sporadic medullary carcinoma of the thyroid].
Topics: 3-Iodobenzylguanidine; Aged; Carcinoma; Female; Humans; Iodobenzenes; Radionuclide Imaging; Thyroid Neoplasms | 1987 |
Radionuclide therapy of neural crest tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carcinoid Tumor; Child; Child, Preschool; Female; Humans; Iodobenzenes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neuroblastoma; Pheochromocytoma; Thyroid Neoplasms | 1987 |
Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Carcinoma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Radionuclide Imaging; Thyroid Neoplasms | 1987 |
Uptake of 131I-MIBG by medullary carcinoma of thyroid in familial cases.
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Radionuclide Imaging; Technetium; Thyroid Neoplasms | 1986 |
[Possibility of using 131I-meta-iodobenzylguanidine in the diagnosis of neuroendocrine tumors differing from pheochromocytomas].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Carcinoma; Child; Child, Preschool; Female; Humans; Infant; Iodobenzenes; Male; Middle Aged; Neuroblastoma; Radionuclide Imaging; Thyroid Neoplasms | 1986 |
Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.
Topics: 3-Iodobenzylguanidine; Carcinoma; Humans; Iodobenzenes; Liver Neoplasms; Male; Radionuclide Imaging; Thyroid Neoplasms | 1986 |
Medullary-thyroid-carcinoma imaging in an animal model: use of radiolabeled anticalcitonin F(ab')2 and meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Animals; Calcitonin; Carcinoma; Humans; Immunoglobulin Fab Fragments; Iodine Radioisotopes; Iodobenzenes; Mesothelioma; Mice; Mice, Nude; Neoplasm Transplantation; Radionuclide Imaging; Thyroid Neoplasms | 1985 |